Cancer
Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress
Published in Medical Verdicts and Law Weekly, October 1st, 2009
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced that approximately 30 studies evaluating the use of Nexavar (sorafenib) tablets across tumor types - as a single agent or in combination with other therapies - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20 - 24 in Berlin.
"The presentations at the ECCO/ESMO conference will continue to build on our large body of data in unresectable liver cancer and advanced kidney cancer where Nexavar has a proven track record," said Dimitris Voliotis, Vice President, Global...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- Absopure Water Company
Taxing Bottled Water Hurts Community Health, Recycling Efforts and Jobs in Michigan - Addiction Medicine
Gambling Addiction Expert Says Treatment Tops Prohibition - Affinion Security Center
Affinion Security Center Launches Benefits to Help Detect and Resolve Medical Identity Theft - Albany Molecular Research, Inc.
AMRI Files New Patent Infringement Lawsuits against Dr. Reddy's Laboratories and Sandoz - Alzheimer Disease
Project Lifesaver International Receives Federal Assistance for the Missing Alzheimer's Patient Assistance Program - American Association for Homecare
Senate Finance Committee Cuts Home Medical Equipment in Reform Package - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
